Jehan Rowlands is a seasoned and experienced regulatory strategist whose career spans over twenty years at companies including Forest, Sanofi, Otsuka, NPS, InfaCare, Actinium, and Rafael. He has worked closely with the FDA to develop and execute regulatory strategies for drug candidates for a wide range of therapeutic indications. Throughout his career, he has contributed to the development of innovative products for unmet medical needs leading to the filing and approval of Namenda, Natpara, and accelerating development and early NDA filing of stannsoporfin for neonatal hyperbilirubinemia while at InfaCare. Jehan most recently joins us from Rafael Pharmaceutical where he was Vice President, Head of Regulatory Affairs.
Jehan received his B.S. in Pharmacy as well as a Doctor of Pharmacy (Pharm.D.) degree from Rutgers University, Ernest Mario School of Pharmacy. He also completed a post-doctoral pharmaceutical industry fellowship jointly sponsored by Rutgers University and Hoffmann-La Roche.